Scientist II

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified

Salary

Not verified

401(k) match

Not verified

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$111,944 U.S. median for this role

Projected growth (BLS Employment Projections)

+13.7% - Much faster than average

Matched to SOC 15-1252 - Data and ML aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Data From the posting source checked Jun 20, 2026

Seniority

Mid From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Scientist II San Francisco Note: This role is currently part of our general interest pool. We are not actively recruiting for it at this time, but we are reviewing submissions. If a strong fit emerges and the role is prioritized, a member of our team will reach out. Thank you for your interest in Multiply Labs. Join the Future of Robotic Biomanufacturing! Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more. Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high-often $500K-$2M per patient-limiting access to only a small fraction of those who need them. As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable. We believe the future of biomanufacturing is robotic-closed, automated, and scalable-ensuring critical therapeutics are accessible to every patient who needs them. Why This Matters We don't just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach patients. The Stack & The Scale The Mission: Build the world's best robots to make life-saving therapies accessible to all. The Technology: Advanced robotic orchestration, high-precision automation, cloud-integrated

Read the full description at jobs.lever.co. FewerJobs shows a preview and links to the original posting.